Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,446,727 papers from all fields of science
Search
Sign In
Create Free Account
Malignant neoplasm of prostate
Known as:
ETURAUHASEN PAHANLAATUINEN KASVAIN
, Malignant Prostate Tumor
, Prostate--Cancer
Expand
A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Benign Prostatic Hyperplasia
Benign prostatic hypertrophy
CTSH gene
CTSH wt Allele
Expand
Narrower (2)
Carcinoma in situ of prostate
adenocarcinoma of the prostate
Broader (1)
Prostatic Neoplasms
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline
Alireza Mahboubian
,
S. K. Hashemein
,
Shadi H. Moghadam
,
F. Atyabi
,
R. Dinarvand
Iranian journal of pharmaceutical research
2010
Corpus ID: 14957651
Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer…
Expand
Review
1993
Review
1993
Prostate cancer trends in Canada: rising incidence or increased detection?
Isra G. Levy
,
Laurie Gibbons
,
P. John
,
Collins
,
D. Perkins
,
Y. Mao
CMAJ : Canadian Medical Association journal…
1993
Corpus ID: 21913316
OBJECTIVES To analyse trends in the incidence and mortality rates of prostate cancer in Canada according to age distribution…
Expand
Highly Cited
1983
Highly Cited
1983
Prostatic cancer induced in MRC rats by N-nitrosobis(2-oxopropyl)-amine and N-nitrosobis(2-hydroxypropyl)amine.
P. Pour
Carcinogenesis
1983
Corpus ID: 44299351
Weekly intragastric treatment with N-nitrosobis(2-oxopropyl)amine or N-nitrosobis(2-hydroxypropyl)amine induced hyperplastic…
Expand
1973
1973
Responses of serum luteinizing hormone and follicle-stimulating hormone levels to synthetic luteinizing hormone-releasing hormone (LH-RH) in various forms of testicular disorders.
K. Isurugi
,
K. Wakabayashi
,
K. Fukutani
,
H. Takayasu
,
B. Tamaoki
Journal of Clinical Endocrinology and Metabolism
1973
Corpus ID: 33375084
ABSTRACT Synthetic luteinizing hormonereleasing hormone (LH-RH) was administered to normal men and to patients with oligospermia…
Expand
Highly Cited
1969
Highly Cited
1969
The results of radical perineal prostatectomy.
H. J. Jewett
Journal of the American Medical Association (JAMA…
1969
Corpus ID: 35995638
Advanced cancer of the prostate is L relatively prevalent, and, in this country, it is now the third most common cause of death…
Expand
1966
1966
A new oral progestational steroid effective in treating prostatic cancer.
Scott Ww
,
Schirmer Hk
1966
Corpus ID: 77901999
Highly Cited
1955
Highly Cited
1955
Occult carcinoma of the prostate; clinical and therapeutic study of eighty-three cases.
L. F. Greene
,
H. Simon
1955
Corpus ID: 31849891
At times the urologist is surprised to learn that a prostate gland with enlargement that he had considered to be benign is found…
Expand
1953
1953
The effect of hormonal therapy of prostatic cancer on serum aldolase.
R. Baker
,
D. Govan
Cancer Research
1953
Corpus ID: 32904194
1. A method is presented for the quantitative determination of the activity of advanced prostatic cancer by the measurement of…
Expand
Review
1951
Review
1951
Serum phosphatase determinations in diagnosis of prostatic cancer; a review of 1,150 cases.
R. M. Nesbit
,
W. Baum
Journal of the American Medical Association
1951
Corpus ID: 44700790
Serum phosphatase determinations have become important aids in diagnosis, particularly the diagnosis of prostatic cancer, but…
Expand
1949
1949
Carcinoma cells in prostatic secretions.
D. D. Albers
,
J. Mcdonald
,
G. J. Thompson
Journal of the American Medical Association
1949
Corpus ID: 29832817
Cancer of the prostate accounts for 8,000 deaths each year in the United States and is clinically the second commonest cancer in…
Expand